CORCEPT THERAPEUTICS INC Basic Shares Outstanding (Weighted Average)
CORCEPT THERAPEUTICS INC (CORT) reported Basic Shares Outstanding (Weighted Average) of 105.38 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-07-29
- CORCEPT THERAPEUTICS INC weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 105.38M shares, a 1.22% increase year-over-year.
- CORCEPT THERAPEUTICS INC weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 104.44M shares, a 0.32% increase year-over-year.
- CORCEPT THERAPEUTICS INC weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 103.69M shares, a 0.04% increase year-over-year.
- CORCEPT THERAPEUTICS INC weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 103.55M shares, a 0.17% increase year-over-year.
- CORCEPT THERAPEUTICS INC weighted average number of shares outstanding, basic for fiscal 2025 was 103.86M shares, a 0.61% increase from fiscal 2024.
- CORCEPT THERAPEUTICS INC weighted average number of shares outstanding, basic for fiscal 2024 was 103.23M shares, a 0.32% decline from fiscal 2023.
- CORCEPT THERAPEUTICS INC weighted average number of shares outstanding, basic for fiscal 2023 was 103.56M shares, a 3.02% decline from fiscal 2022.
- CORCEPT THERAPEUTICS INC weighted average number of shares outstanding, basic for fiscal 2022 was 106.79M shares, a 7.67% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 105.38M shares 10-Q · filed 2026-07-29 | 104.91M shares 10-Q · filed 2026-07-29 | 104.50M shares derived: average of 3 quarters · filed 2026-07-29 | 104.26M shares derived: average of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | 104.44M shares 10-Q · filed 2026-04-30 | 104.06M shares derived: average of 2 quarters · filed 2026-04-30 | 103.89M shares derived: average of 3 quarters · filed 2026-04-30 | 103.95M shares derived: average of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | 103.69M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 103.62M shares derived: average of 2 quarters · filed 2026-02-24 | 103.78M shares derived: average of 3 quarters · filed 2026-07-29 | 103.86M shares 10-K · filed 2026-02-24 |
| 2025-09-30 | 103.55M shares 10-Q · filed 2025-11-04 | 103.83M shares derived: average of 2 quarters · filed 2026-07-29 | 103.92M shares 10-Q · filed 2025-11-04 | 103.85M shares derived: average of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | 104.11M shares 10-Q · filed 2026-07-29 | 104.11M shares 10-Q · filed 2026-07-29 | 103.95M shares derived: average of 3 quarters · filed 2026-07-29 | 103.81M shares derived: average of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | 104.11M shares 10-Q · filed 2026-04-30 | 103.88M shares derived: average of 2 quarters · filed 2026-04-30 | 103.71M shares derived: average of 3 quarters · filed 2026-04-30 | 103.56M shares derived: average of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | 103.65M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 103.51M shares derived: average of 2 quarters · filed 2026-02-24 | 103.38M shares derived: average of 3 quarters · filed 2026-02-24 | 103.23M shares 10-K · filed 2026-02-24 |
| 2024-09-30 | 103.37M shares 10-Q · filed 2025-11-04 | 103.24M shares derived: average of 2 quarters · filed 2025-11-04 | 103.09M shares 10-Q · filed 2025-11-04 | 102.93M shares derived: average of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | 103.12M shares 10-Q · filed 2025-07-31 | 102.95M shares 10-Q · filed 2025-07-31 | 102.78M shares derived: average of 3 quarters · filed 2026-02-24 | 102.59M shares derived: average of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | 102.79M shares 10-Q · filed 2025-05-05 | 102.62M shares derived: average of 2 quarters · filed 2026-02-24 | 102.42M shares derived: average of 3 quarters · filed 2026-02-24 | 102.30M shares derived: average of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | 102.44M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | 102.23M shares derived: average of 2 quarters · filed 2026-02-24 | 102.14M shares derived: average of 3 quarters · filed 2026-02-24 | 103.56M shares 10-K · filed 2026-02-24 |
| 2023-09-30 | 102.01M shares 10-Q · filed 2024-10-30 | 101.99M shares derived: average of 2 quarters · filed 2024-10-30 | 103.93M shares 10-Q · filed 2024-10-30 | 104.89M shares derived: average of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | 101.96M shares 10-Q · filed 2024-07-29 | 104.91M shares 10-Q · filed 2024-07-29 | 105.85M shares derived: average of 3 quarters · filed 2025-02-26 | 106.17M shares derived: average of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | 107.89M shares 10-Q · filed 2024-05-01 | 107.80M shares derived: average of 2 quarters · filed 2025-02-26 | 107.57M shares derived: average of 3 quarters · filed 2025-02-26 | 107.25M shares derived: average of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | 107.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | 107.42M shares derived: average of 2 quarters · filed 2025-02-26 | 107.04M shares derived: average of 3 quarters · filed 2025-02-26 | 106.79M shares 10-K · filed 2025-02-26 |
| 2022-09-30 | 107.13M shares 10-Q · filed 2023-11-01 | 106.71M shares derived: average of 2 quarters · filed 2023-11-01 | 106.48M shares 10-Q · filed 2023-11-01 | 108.29M shares derived: average of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | 106.29M shares 10-Q · filed 2023-08-02 | 106.15M shares 10-Q · filed 2023-08-02 | 108.67M shares derived: average of 3 quarters · filed 2024-02-15 | 110.45M shares derived: average of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | 106.01M shares 10-Q · filed 2023-05-03 | 109.87M shares derived: average of 2 quarters · filed 2024-02-15 | 111.84M shares derived: average of 3 quarters · filed 2024-02-15 | 112.95M shares derived: average of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | 113.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | 114.76M shares derived: average of 2 quarters · filed 2024-02-15 | 115.27M shares derived: average of 3 quarters · filed 2024-02-15 | 115.65M shares 10-K · filed 2024-02-15 |
| 2021-09-30 | 115.79M shares 10-Q · filed 2022-11-03 | 116.04M shares derived: average of 2 quarters · filed 2022-11-03 | 116.30M shares 10-Q · filed 2022-11-03 | 116.31M shares derived: average of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | 116.29M shares 10-Q · filed 2022-08-04 | 116.56M shares 10-Q · filed 2022-08-04 | 116.48M shares derived: average of 3 quarters · filed 2023-02-28 | 116.29M shares derived: average of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | 116.82M shares 10-Q · filed 2022-05-05 | 116.57M shares derived: average of 2 quarters · filed 2023-02-28 | 116.29M shares derived: average of 3 quarters · filed 2023-02-28 | 115.97M shares derived: average of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | 116.33M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | 116.03M shares derived: average of 2 quarters · filed 2023-02-28 | 115.69M shares derived: average of 3 quarters · filed 2023-02-28 | 115.41M shares 10-K · filed 2023-02-28 |
| 2020-09-30 | 115.73M shares 10-Q · filed 2021-11-03 | 115.37M shares derived: average of 2 quarters · filed 2021-11-03 | 115.11M shares 10-Q · filed 2021-11-03 | 114.92M shares derived: average of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | 115.01M shares 10-Q · filed 2021-07-29 | 114.79M shares 10-Q · filed 2021-07-29 | 114.64M shares derived: average of 3 quarters · filed 2022-02-15 | 114.45M shares derived: average of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | 114.58M shares 10-Q · filed 2021-05-06 | 114.46M shares derived: average of 2 quarters · filed 2022-02-15 | 114.27M shares derived: average of 3 quarters · filed 2022-02-15 | 114.28M shares derived: average of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | 114.35M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | 114.11M shares derived: average of 2 quarters · filed 2022-02-15 | 114.19M shares derived: average of 3 quarters · filed 2022-02-15 | 114.35M shares 10-K · filed 2022-02-15 |
| 2019-09-30 | 113.88M shares 10-Q · filed 2020-11-03 | 114.11M shares derived: average of 2 quarters · filed 2020-11-03 | 114.35M shares 10-Q · filed 2020-11-03 | 114.56M shares derived: average of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | 114.34M shares 10-Q · filed 2020-08-04 | 114.59M shares 10-Q · filed 2020-08-04 | 114.79M shares derived: average of 3 quarters · filed 2021-02-23 | 115.04M shares derived: average of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | 114.84M shares 10-Q · filed 2020-05-04 | 115.02M shares derived: average of 2 quarters · filed 2021-02-23 | 115.28M shares derived: average of 3 quarters · filed 2021-02-23 | 115.33M shares derived: average of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | 115.19M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | 115.49M shares derived: average of 2 quarters · filed 2021-02-23 | 115.49M shares derived: average of 3 quarters · filed 2021-02-23 | 115.34M shares 10-K · filed 2021-02-23 |
| 2018-09-30 | 115.80M shares 10-Q · filed 2019-11-07 | 115.64M shares derived: average of 2 quarters · filed 2019-11-07 | 115.39M shares 10-Q · filed 2019-11-07 | 115.14M shares derived: average of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | 115.49M shares 10-Q · filed 2019-08-01 | 115.19M shares 10-Q · filed 2019-08-01 | 114.92M shares derived: average of 3 quarters · filed 2020-02-24 | 114.59M shares derived: average of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | 114.88M shares 10-Q · filed 2019-05-09 | 114.63M shares derived: average of 2 quarters · filed 2020-02-24 | 114.29M shares derived: average of 3 quarters · filed 2020-02-24 | 114.03M shares derived: average of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | 114.38M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | 113.99M shares derived: average of 2 quarters · filed 2020-02-24 | 113.74M shares derived: average of 3 quarters · filed 2020-02-24 | 113.53M shares 10-K · filed 2020-02-24 |
| 2017-09-30 | 113.60M shares 10-Q · filed 2018-11-02 | 113.43M shares derived: average of 2 quarters · filed 2018-11-02 | 113.24M shares 10-Q · filed 2018-11-02 | 112.91M shares derived: average of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | 113.25M shares 10-Q · filed 2018-08-09 | 113.06M shares 10-Q · filed 2018-08-09 | 112.68M shares derived: average of 3 quarters · filed 2019-02-26 | 112.17M shares derived: average of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | 112.87M shares 10-Q · filed 2018-05-09 | 112.39M shares derived: average of 2 quarters · filed 2019-02-26 | 111.81M shares derived: average of 3 quarters · filed 2019-02-26 | 111.37M shares derived: average of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | 111.91M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | 111.28M shares derived: average of 2 quarters · filed 2019-02-26 | 110.87M shares derived: average of 3 quarters · filed 2019-02-26 | 110.57M shares 10-K · filed 2019-02-26 |
| 2016-09-30 | 110.65M shares 10-Q · filed 2017-11-03 | 110.34M shares derived: average of 2 quarters · filed 2017-11-03 | 110.12M shares 10-Q · filed 2017-11-03 | 109.89M shares derived: average of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | 110.03M shares 10-Q · filed 2017-08-02 | 109.85M shares 10-Q · filed 2017-08-02 | 109.64M shares derived: average of 3 quarters · filed 2018-02-28 | 109.34M shares derived: average of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | 109.66M shares 10-Q · filed 2017-05-02 | 109.44M shares derived: average of 2 quarters · filed 2018-02-28 | 109.11M shares derived: average of 3 quarters · filed 2018-02-28 | 108.80M shares derived: average of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | 109.22M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | 108.84M shares derived: average of 2 quarters · filed 2018-02-28 | 108.52M shares derived: average of 3 quarters · filed 2018-02-28 | 106.88M shares 10-K · filed 2018-02-28 |
| 2015-09-30 | 108.46M shares 10-Q · filed 2016-11-02 | 108.17M shares derived: average of 2 quarters · filed 2016-11-02 | 106.10M shares 10-Q · filed 2016-11-02 | |
| 2015-06-30 | 107.87M shares 10-Q · filed 2016-08-03 | 104.91M shares 10-Q · filed 2016-08-03 | ||
| 2014-12-31 | 100.98M shares 10-K · filed 2017-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |